CTL banner 2015

CTL_Icon_CTMBarnett International/CHI’s Fifth Annual
Mastering Clinical Trial Monitoring
Optimizing Site Performance and Improving Efficiency with Risk-Based Monitoring
June 2-3, 2014, Hilton Boston Back Bay, Boston, MA


At this time of change and growth for clinical trial monitors, Barnett International/CHI is pleased to announce a Call for Speakers for our fifth annual Mastering Clinical Trial Monitoring conference. Focusing exclusively on the changing landscape and evolving role of clinical trial monitors, this event will bring together thought leaders to share their experiences and insights related to the industry’s most topical issues such as the FDA’s Final Guidance on Risk-Based Monitoring, the impact of TransCelerate’s efforts in the industry, monitoring international clinical trials, and quality systems-based approaches to monitoring. We seek thought leaders to provide insights, case studies, hands-on activities, and take-away tools for monitors.


CTL_Icon_VMGBarnett International/CHI’s Third Annual
Vendor Management in Clinical Trials
Ensuring Quality through Effective Assessment,
Qualification, Auditing, and Oversight

June 2-3, 2014, Hilton Boston Back Bay, Boston, MA


With growing reliance on third party providers in clinical trials, the need for effective selection and oversight of vendors is more important than ever. Barnett International/CHI is pleased to announce a Call for Speaker Proposals for our third annual Vendor Management in Clinical Trials conference, an event that addresses the need for quality in the assessment, contracting, implementation, auditing, and ongoing oversight of third party vendors. With growing regulatory expectations for a quality systems-based approach to GCP compliance, sponsors must be certain that their third party vendor partners are “inspection ready.” This event will feature thought leaders who will share their experiences with all types of third party vendor relationships, including clinical research organizations, core labs, and software providers. Abstracts are sought regarding risk-based approaches to vendor management, all phases of the vendor relationship from assessment to oversight. Submissions from sponsor/vendor partners are encouraged. Submissions that feature case studies, take-away tools, perspectives on the current regulatory environment, breakout groups, and interactive activities will be given preference.


CTL_Icon_CTAUBarnett International/CHI’s Fourth Annual
Clinical Auditing Forum
Ensuring Audit Readiness and GCP Compliance
Across Clinical Research Functions

June 4-5, 2014, Hilton Boston Back Bay, Boston, MA



Barnett International/CHI is pleased to announce a Call for Speaker Proposals for our fourth annual Clinical Auditing Forum, an event focused on risk-based auditing techniques, quality systems-based approaches to auditing and ensuring GCP inspection readiness. Building on the success of previous years’ events, we invite thought leaders to submit their abstracts related to strengthening auditing programs, ensuring compliance, managing non-compliance, RCA and CAPA, and international auditing techniques. We invite abstracts with real-world examples of risk-based approaches to auditing sites, systems, and providers. We seek thought leaders to provide insights, case studies, hands-on activities, and take-away tools for clinical auditors.


CTL_Icon_CPMBarnett International/CHI’s Fifth Annual
Clinical Project Management Forum
Risk-Based Approaches to Maximizing Trial Performance
June 4-5, 2014, Hilton Boston Back Bay, Boston, MA


The effects of globalization, social media, and risk-based approaches to clinical trials have had a profound effect on project managers. Barnett International/CHI is pleased to announce a Call for Speaker Proposals for our fifth annual Clinical Project Management Forum, an event that addresses the many responsibilities of clinical project managers. We are seeking submissions that address evolving issues: ensuring the delivery of high quality and highly valuable data, improving performance, optimizing patient recruitment, mitigating risk, and navigating the various challenges and opportunities of global clinical trials. Submissions that feature case studies, take-away tools, perspectives on the current regulatory environment, breakout groups, and interactive activities will be given preference.